Concordance Between Antibiotic Resistance Genes and Susceptibility in Symptomatic Urinary Tract Infections
David Baunoch,Natalie Luke,Dakun Wang,Annah Vollstedt,Xinhua Zhao,Dicken S C Ko,Shuguang Huang,Patrick Cacdac,Larry T Sirls
DOI: https://doi.org/10.2147/IDR.S323095
2021-08-19
Infection and Drug Resistance
Abstract:David Baunoch, 1, 2 Natalie Luke, 2 Dakun Wang, 3 Annah Vollstedt, 4 Xinhua Zhao, 5 Dicken SC Ko, 6 Shuguang Huang, 5 Patrick Cacdac, 2 Larry T Sirls 4 1 Research/Development, Pathnostics, Irvine, CA, USA; 2 Clinical Affairs, Pathnostics, Irvine, CA, USA; 3 Medical Writing, Stat4ward, Pittsburgh, PA, USA; 4 Women's Urology and Pelvic Health Center, Beaumont Hospital, Royal Oak, MI, USA; 5 Statistics, Stat4ward, Pittsburgh, PA, USA; 6 Department of Bio Med Surgery, Warren Alpert Medical School of Brown University, Providence, RI, USA Correspondence: David Baunoch Email Purpose: Studies have shown that multiple genes influence antibiotic susceptibility, but the relationship between genotypic and phenotypic antibiotic susceptibility is unclear. We sought to analyze the concordance between the presence of antibiotic resistance (ABR) genes and antibiotic susceptibility results in urine samples collected from patients with symptomatic urinary tract infection (UTI). Patients and Methods: Urine samples were collected from patients presenting to 37 geographically disparate urology clinics across the United States from July 2018 to February 2019. Multiplex polymerase chain reaction was used to detect 27 ABR genes. In samples containing at least one culturable organism at a concentration of ≥ 10 4 cells per mL, pooled antibiotic susceptibility testing (P-AST), which involves simultaneous growing all detected bacteria together in the presence of antibiotic and then measure susceptibility, was performed against 14 antibiotics. The concordance rate between the ABR genes and the P-AST results was generated for the overall group. The concordance rates for each antibiotic between monomicrobial and polymicrobial infection were compared using chi-square test. Results: Results from ABR gene detection and P-AST of urine samples from 1155 patients were included in the concordance analysis. Overall, there was a 60% concordance between the presence or absence of ABR genes and corresponding antimicrobial susceptibility with a range of 49– 78% across antibiotic classes. Vancomycin, meropenem, and piperacillin/tazobactam showed significantly lower concordance rates in polymicrobial infections than in monomicrobial infections. Conclusion: Given the 40% discordance rate, the detection of ABR genes alone may not provide reliable data to make informed clinical decisions in UTI management. However, when used in conjunction with susceptibility testing, ABR gene data can offer valuable clinical information for antibiotic stewardship. Keywords: urinary tract infection, antibiotic resistance, antibiotic resistance genes, bacteria, culture, antibiotic susceptibility test, polymerase chain reaction Urinary tract infection (UTI) is common among geriatric populations 1 and contributes to high healthcare costs in the United States. 2 Current clinical urine tests, such as standard urine culture (SUC) are limited in their scope and parameters. Additionally, turnaround time can reach up to 3–5 days for SUC and antibiotic susceptibility testing (AST), 3–5 which leads to a reliance on empiric treatment. 5 To effectively treat geriatric patients, developing novel tests to accurately and rapidly identify uropathogens and assess antibiotic susceptibility is necessary to determine who will require what therapy. 3–5 Amidst the rising rate of multidrug resistant organisms, a variety of technologies used for rapid phenotypic growth-based antibiotic susceptibility testing, such as digital time-lapse microscopy, morphokinetic cellular analysis, and MALDI-TOF direct-on-target microdroplet growth assays, have been investigated. However, most of these technologies are still far from being used in routine clinical diagnostics. 6–9 During the past decade, advances in polymerase chain reaction (PCR) technology and other DNA target amplification techniques have resulted in molecular diagnostics becoming a revolutionary method in the field of infectious disease. 3–5 Clinicians and researchers have started using these more sensitive and specific tests to detect microorganisms 10 , 11 and antibiotic resistance (ABR) genes 12–14 to understand urobiome and more effectively manage UTIs. Whereas the ro -Abstract Truncated-